Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Charles J. Fisher
AddedMar 31, 2024
UpdatedMay 31, 2026
Charles J. Fisher

Charles J. Fisher

CEO, Margaux

Crunchbase

Charles J. Fisher's Career

Margaux
Margaux

New York City, NY, US

CEO· C-Suite · Management
SeaStar Medical
SeaStar Medical

Ann Arbor, MI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Charles J. Fisher's Career

Margaux
Margaux
Series A$5.3M842015New York City, NY, US
CEO· C-Suite · Management

Leadership at Margaux

Sarah PiersonSarah PiersonCo-Founder
Alexa BuckleyAlexa BuckleyCo-Founder

Similar to Margaux

Pashion FootwearPashion FootwearSan Luis Obispo, CA, USFootwear, High Heelsest. 2016Pashion FootwearSan Luis Obispo, CA, US · est. 2016

Pashion Footwear: A stylish lifestyle brand offering versatile, convertible high heels online.

Seed · $3.2M17
ProtégéProtégéScottsdale, AZ, USFootwear, High HeelsProtégéScottsdale, AZ, US

Stylish, comfortable high heels brand for confident women on the move.

Seed · $250k35
M.GemiM.GemiBoston, MA, USHandbags, Shoesest. 2014M.GemiBoston, MA, US · est. 2014

Italian-origin M.Gemi offers handcrafted, stunning shoes directly to customers.

Series B · $81.5M29
ModamiModamiSan Carlos, CA, USApparel, Footwearest. 2011ModamiSan Carlos, CA, US · est. 2011

ModaMi, Inc.: Your online destination for women's fashion, offering a wide range of clothing and shoes since 2011.

Public · $250k6
SeaStar Medical
SeaStar Medical
Series C$50.2M52007Ann Arbor, MI, US
Board Member· Board

Leadership at SeaStar Medical

Alvin VitangcolAlvin VitangcolBoard Member
Michael BunkerMichael BunkerBoard Member

Similar to SeaStar Medical

CytophilCytophilEast Troy, WI, USMedical Devicesest. 2005CytophilEast Troy, WI, US · est. 2005

Cytophil develops, manufactures, and distributes implantable medical devices for physicians and companies.

Angel · $526k12
CytoSorbentsCytoSorbentsMonmouth Junction, NJ, USMedical Devicesest. 2014CytoSorbentsMonmouth Junction, NJ, US · est. 2014

NJ-based CytoSorbents Corp. innovates blood purification tech for acute and chronic health issues.

Public · $39.8M198
BiophyxBiophyxClawson, MI, USMedical Equipmentest. 2019BiophyxClawson, MI, US · est. 2019

Biophyx: A leading manufacturer of advanced medical equipment.

Seed · $300k1
Piraeus MedicalPiraeus MedicalRochester, MN, USMedical Devicesest. 2021Piraeus MedicalRochester, MN, US · est. 2021

Piraeus Medical: A stealth-mode healthcare company creating devices for enhanced patient care.

Seed · $3.1k6

Charles J. Fisher's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Charles J. Fisher

Ray ShealyRay ShealyCo-Founder & CEO · TicketFireMark LavelleMark LavelleBoard Member · Deep Lake CapitalJeff RansdellJeff RansdellCo-Founder · Fuel Venture CapitalRonald GoldRonald GoldBoard Member · NJ BioVenkat KrishnanVenkat KrishnanCEO · BionpharmaJeff McLarenJeff McLarenBoard Member · HealthStream